Name | N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-phthalimide |
---|---|
Synonyms |
NAN 190
1-(2-methoxyphenyl)-4-(4-phthalimidobutyl)piperazine 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine hydrobromide 1-(methoxyphenyl)-4-<4-(2-phthalimido)butyl>-piperazine hydrobromide |
Description | NAN-190 is a serotonin receptor 5-HT antagonist. NAN-190 is a selective antagonist of 5-HT1A.Target: 5-HT in vitro: NAN-190 is a 5-HT1A antagonist. [3] NAN-190 is a selective antagonist of 5-HT1A. [1]in vivo: NAN-190 (0.5 mg/kg, ip), as a 5-HT1A receptor antagonist, is injected concomitantly with the effective dose of fluoxetine. NAN-190 (5-HT1A receptor antagonist) reverses the catalepsy-improving effect of fluoxetine in 6-OHDA lesioned rats. [2] |
---|---|
Related Catalog | |
Target |
5-HT1 Receptor |
References |
Molecular Formula | C23H27N3O3 |
---|---|
Molecular Weight | 393.48 |
Exact Mass | 393.20500 |
PSA | 53.09000 |
LogP | 2.83440 |
Precursor 0 | |
---|---|
DownStream 1 | |